Exchange Traded Concepts’s Haemonetics HAE Stock Holding History

Exchange Traded Concepts’s Portfolio HAE Stock Details HAE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.05M	Buy	14,001 +39	+0.3%	+$2.5K	﹤0.01%	914
2026 Q1	$787K	Buy	13,962 +12,520	+868%	+$815K	0.01%	907
2025 Q4	$116K	Buy	+1,442	New	+$96.9K	﹤0.01%	1344
2024 Q1	–	Sell	-6,669	Closed	-$570K	–	1321
2023 Q4	$570K	Hold	6,669	–	–	0.02%	580
2023 Q3	$597K	Buy	+6,669	New	+$595K	0.02%	519
2021 Q3	–	Sell	-3,857	Closed	-$257K	–	1165
2021 Q2	$257K	Buy	3,857 +325	+9%	+$23K	0.01%	726
2021 Q1	$392K	Sell	3,532 -446	-11%	-$55.2K	0.01%	634
2020 Q4	$472K	Buy	3,978 +180	+5%	+$19.4K	0.02%	377
2020 Q3	$331K	Buy	3,798 +873	+30%	+$76.3K	0.02%	433
2020 Q2	$262K	Buy	+2,925	New	+$295K	0.04%	416

Other funds holding HAE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Exchange Traded Concepts's HAE Position: Q2 2026 in Review

Exchange Traded Concepts increased its Haemonetics (HAE) stake by 0.28% in Q2 2026, buying an estimated $2.5K and bringing the position to 14,001 shares worth $1.05M. The position accounts for ﹤0.01% of the portfolio, ranked #914.

Exchange Traded Concepts first reported a position in HAE in Q2 2020 and has held it in 10 quarters since. 329 funds tracked by Wall St. Rank hold HAE as of Q2 2026.

Exchange Traded Concepts held 14,001 shares of Haemonetics worth $1.05M as of Q2 2026.
Exchange Traded Concepts bought 39 Haemonetics shares in Q2 2026, an estimated $2.5K.
Haemonetics made up ﹤0.01% of Exchange Traded Concepts's portfolio in Q2 2026, its #914 holding.
Exchange Traded Concepts first reported a position in Haemonetics in Q2 2020 and has held it in 10 quarters since.
329 funds tracked by Wall St. Rank held Haemonetics as of Q2 2026.

Based on Exchange Traded Concepts's 13F filing for Q2 2026, filed 22 Jul 2026.